Loading…
The Technology Development Board signed an agreement on August 10, 2026 with Visakhapatnam-based Griva Healthcare to commercialise GrivaVision.
GrivaVision is an indigenous AI-powered portable digital colposcope for cervical cancer screening.
It is classified as a Class B non-invasive medical device and holds a CDSCO manufacturing licence.
Manufacturing will move from AIC-AMTZ Medivalley, Visakhapatnam to a commercial plant in Kollam, Kerala.
More than 50% of the device's components are sourced indigenously.
Colposcopy is a clinical procedure that examines the cervix, vagina and vulva under magnification to spot abnormal tissue. GrivaVision digitises this by combining proprietary Indian-patented hardware, advanced optics and a high-definition camera with AI-assisted software that flags pre-cancerous changes in cervical lesions during routine check-ups. Because cervical cancer develops slowly through detectable pre-cancerous stages, screening is unusually effective at preventing deaths — making a portable, lower-cost device valuable in settings without specialist facilities.
Simple Analogy: A magnifying camera with a trained second pair of eyes built in, flagging what a clinician should look at more closely.
Provides financial assistance to Indian companies commercialising indigenous technology
National regulator for drugs, cosmetics and medical devices, including manufacturing licences
General Awareness > Science and Technology in News
GS Paper III > Science and Technology > Indigenous Technology and Health
An instrument used to examine the cervix, vagina and vulva under magnification.
The international standard for quality management systems specific to medical devices.
India's mission to build digital health infrastructure, including health IDs and interoperable health records.